Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer

Go back to Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
(NASDAQ: ACRS) Delayed: 6.02 --0 (-0%)
Previous Close $6.02    52 Week High $33.88 
Open $6.02    52 Week Low $14.12 
Day High $6.02    P/E N/A 
Day Low $6.02    EPS $0.00 
Volume 1,630